首页> 外文OA文献 >Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial

【2h】

Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial

机译：植入药物洗脱支架后12个月和48个月双重抗血小板治疗的疗效和安全性：OPTImal DUAL抗血小板治疗（OPTIDUAL）试验：一项随机对照试验的研究方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gérard Helft; Claude Le Feuvre; Jean Louis Georges; Didier Carrie; Florence Leclercq; Hélène Eltchaninoff; Alain Furber; Fabrice Prunier; Laurent Sebagh; Simon Cattan; Guillaume Cayla; Eric Vicaut; Jean-Philippe Metzger;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial [J] . Gérard Helft, Claude Le Feuvre, Jean Louis Georges, Trials . 2013,第1期

机译：药物洗脱支架植入后双重抗血小板治疗12个月与48个月的疗效和安全性：OPTImal DUAL抗血小板治疗（OPTIDUAL）试验：一项随机对照试验的研究方案
2. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. [J] . Mauri L, Kereiakes DJ, Normand SL, The American heart journal . 2010,第6期

机译：双重抗血小板治疗研究的原理和设计，这是一项前瞻性，多中心，随机，双盲试验，旨在评估经药物洗脱支架或裸露经皮冠状动脉介入治疗的受试者12个月与30个月双重抗血小板治疗的有效性和安全性金属支架置入术治疗冠状动脉病变。
3. A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial" [J] . Kedhi Elvin, Fabris Enrico, van der Ent Martin, The American heart journal . 2017,第期

机译：6个月与12个月双抗血小板治疗的前瞻性，随机开放式试验，在ST升高的药物植入植入后的毒液植入：“DAPT-STEMI试验”的理由和设计
4. Impact of Complementary Therapies via Mobile Technologies on Icelandic Same Day Surgical Patients' Reports of Anxiety, Pain and Self-Efficacy in Healing: A Randomized Controlled Trial in Process [C] . Margaret M. Hansen MEDINFO . 2013

机译：互补疗法通过移动技术对冰岛同日外科患者的影响焦虑，痛苦和自我疗效愈合中的报告：过程中的随机对照试验
5. Feasibility Study of a Randomized Controlled Trial Protocol to Examine the Effectiveness of Auriculotherapy (AT) in Improving Sleep Condition and Glycaemic Control in Clients with Type 2 Diabetes. [D] . Kwan, Yee Mei. 2013

机译：一项随机对照试验方案的可行性研究，以检查耳穴疗法（AT）改善2型糖尿病患者睡眠状况和血糖控制的有效性。
6. Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial [O] . Gérard Helft, Claude Le Feuvre, Jean Louis Georges, 2013

机译：植入药物洗脱支架后12个月和48个月双重抗血小板治疗的疗效和安全性：OPTImal DUAL抗血小板治疗（OPTIDUAL）试验：一项随机对照试验的研究方案
7. TCT-8 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent: Prospective, Randomized, Multicenter Trial [O] . Lee Byoung Kwon, Bum-Kee Hong, Yoon Young Won, 2013

机译：将第二代药物洗脱支架植入Biolimus洗脱支架与Zotarolimus洗脱支架之后的TCT-8 6个月和12个月双重抗血小板治疗：前瞻性，随机，多中心试验

Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial

著录项

引文网络

相似文献

相关主题

期刊订阅